+359.889.669.399 office@ribexconsulting.com

Our Activities

What we Do Best
 

A brief list of the activities we do and services we offer to our clients across the globe.

Activities

We Can Do it All

Consultancy

Consultancy in the field of healthcare, healthcare management, health insurance, pharmaceutical production and quality assurance, GMP-licensing, rich expertise in health and drug legislation, hospitals and out-patient centres management.

Trade

Core business activity is the commercialisation of medicinal products, medical devices and other health products. Ribex Consulting has built a highly motivated team with a high degree of dedication and professionalism, aligned with the goals and strategies of the company. We are a global logistics company specialised in the supply chain and distribution of medicinal products, medical devices and other pharmaceuticals. We have deep knowledge of the requirements of the international markets and logistics, which allows us to provide custom-made follow-up service to our clients and partners.

 

Ribex Consulting provides clients with a wide, differentiated and adapted offer of pharmaceutical products, compliant with European and US quality requirements.

 

Drug and Pricing Legislation

Capabilities for tailored development of full drug and pricing legislation for the Governments – 3 years project in African countries, with substantial regional impact.

Project management - QC Lab

A WHO accredited Quality Control Laboratory will be built in the capital of the country. The QC Lab will be built by Ribex Consulting as a turn-key project. The QC Lab will guarantee the level of quality of all imported and locally produced products and may be also a service provider for a wider region.
The QC Lab will be built in 3 years, with a possibility of extended non-pharmaceutical production for hospital use. The specialists will be additionally educated in EU and further trained locally by Subject Matter Experts (SME). The first cohort of local specialists will be studying in a Medical University in EU. In the next 7 years, 2 more cohorts of local specialists will graduate and be trained either in EU or at the QC Lab. In 10 years, there will be a world class QC Lab, operated by educated and trained locals.
The total investment for a 5 years period is > US$ 50,000,000.

GMP pharmaceutical production

A full fledged GMP-certified pharmaceutical manufacturing site will be built in the country. As the pharmaceutical production is heavily regulated and GMP guidelines provide guidance for manufacturing, testing, and quality assurance in order to ensure that a manufactured product is safe for human consumption or use, education and training of people is crucial for the success of a venture like this.
Therefore, to secure the GMP-compliance, Ribex Consulting provides access to an experienced Medical University and expertise, long-term education and practical training of local specialists, as well as mitigation strategy for the financial and political risks. This will facilitate the project development, training of people and will secure the successful launch and future transition to more technological production in the country.
In the first 3 years, non-pharmaceutical production for hospital products will be established, as well, production site for labeling and secondary packaging of solid forms, vials and ampules.

Investment planning

Forecasting healthcare investments, risk mitigation and ROI planning.
We focus on establishing strategies, transfer and adapt knowledge and experience from the best cases around the world. Quality and excellence are our primary goal. Ribex Consulting follows the demanding paths in compliance with the best practices.

Process

Try Our Trademarked Process

Research & Analysis

Roadmap planning

Execute & Monitor

Trusted by Medical Universities, Financial powerhouses, Hedge funds and Investment banks, Leading global producers and suppliers of healthcare products and services